
04 February 2026Publication
Genomics x AI in the UAE
Examining the UAE’s leadership in genomics and AI, with key insights ahead of WHX 2026 (previously Arab Health).
From smartphone applications and wearable technology which we use to track our sleeping patterns or fitness or technology which is used to diagnose and treat illnesses or injuries to social media communities supporting patients suffering from the same conditions, digital health is already changing our lives and disrupting existing business models.
Organisations used to operating along traditional sector lines and within recognised industry norms are rethinking their business models to tap into the seemingly limitless potential offered by digital health. Organisations will need to consider new and unfamiliar issues to ensure that legal, regulatory and other risks associated with this innovation are mitigated appropriately.
Through our team of lawyers operating across our international network, we can offer organisations what they need: the best business-focused legal and regulatory advice in a fast-changing healthcare environment.
We assisted a global pharmaceutical eon a number of data protection projects, including in respect of international data transfers, data protection issues in the context of outsourcing and cloud computing transactions, disclosure of data relating to payments to healthcare professionals, as well as social media monitoring.
We advised AMHRA (UK Medicines and Healthcare Products Regulatory Agency) on the procurement of a significant IT system from Accenture and Oracle as well as on the outsourcing of IT infrastructure and software development services to Accenture across two generations of outsourcing contracts.
We provided guidance to an international pharmaceutical company on the structure of data flows and the applicable regulatory requirements on the implementation of a platform providing online assistance to patients during the course of their treatment.
If you have any questions, contact a member of the Digital Health team for assistance:

04 February 2026Publication
Examining the UAE’s leadership in genomics and AI, with key insights ahead of WHX 2026 (previously Arab Health).

15 January 2026 Publication
EMA and FDA published 10 AI principles for medicinal product development, focusing on ethics, risk, standards, and transparency; further guidance to follow.
_11zon.jpg?width=380&width=380&format=webply&auto=webp)
08 January 2026 Publication
The EC has published a proposal that may result in (IV)MD no longer being subject to AIA HRAIS requirements.

18 December 2025 Publication
2026 will see several important legislative reforms and new initiatives that are expected to shape the sector’s operations and strategic priorities.
.jpg?width=380&width=380&format=webply&auto=webp)
18 December 2025 Publication
The new Directive (EU) 2024/2853 strengthens injured parties’ protection and redefines liability, burden of proof, and evidence rules in the supply chain.